These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37277840)

  • 1. Decision curve analysis: confidence intervals and hypothesis testing for net benefit.
    Vickers AJ; Van Claster B; Wynants L; Steyerberg EW
    Diagn Progn Res; 2023 Jun; 7(1):11. PubMed ID: 37277840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
    van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
    Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value-of-Information Analysis for External Validation of Risk Prediction Models.
    Sadatsafavi M; Lee TY; Wynants L; Vickers AJ; Gustafson P
    Med Decis Making; 2023 Jul; 43(5):564-575. PubMed ID: 37345680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision curve analysis to evaluate the clinical benefit of prediction models.
    Vickers AJ; Holland F
    Spine J; 2021 Oct; 21(10):1643-1648. PubMed ID: 33676020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
    Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies.
    Rousson V; Zumbrunn T
    BMC Med Inform Decis Mak; 2011 Jun; 11():45. PubMed ID: 21696604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision curve analysis confirms higher clinical utility of multi-domain versus single-domain prediction models in patients with open abdomen treatment for peritonitis.
    Huber M; Schober P; Petersen S; Luedi MM
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):63. PubMed ID: 37024840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical inference for net benefit measures in biomarker validation studies.
    Marsh TL; Janes H; Pepe MS
    Biometrics; 2020 Sep; 76(3):843-852. PubMed ID: 31732971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products.
    Wen S; Zhang L; Yang B
    Value Health; 2014 Jul; 17(5):619-28. PubMed ID: 25128056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical inference for decision curve analysis, with applications to cataract diagnosis.
    Sande SZ; Li J; D'Agostino R; Yin Wong T; Cheng CY
    Stat Med; 2020 Sep; 39(22):2980-3002. PubMed ID: 32667093
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.